Planet 13 Holdings (PLNH) Restructuring Costs (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Restructuring Costs came in at $2.2 million in Q1 2026, down 17.97% year-on-year from $2.7 million in Q1 2025, and up 16.24% on a QoQ basis from $1.9 million in Q4 2025.
Planet 13 Holdings (PLNH) Restructuring Costs (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Restructuring Costs data on file, last reported at $2.2 million in Q1 2026.
- On a quarterly basis, Restructuring Costs fell 17.97% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $8.6 million, a 1.97% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, up 18.21% from the prior year.
- Restructuring Costs for Q1 2026 stood at $2.2 million, up from $1.9 million in the prior quarter.
- Over the last five years, Restructuring Costs for PLNH reached as high as $2.7 million in Q1 2025 and fell as low as $639164.0 in Q1 2022.
- Historically, Restructuring Costs has averaged $1.7 million across 5 years, with a median of $1.7 million in 2022.
- On a YoY basis, Restructuring Costs climbed as much as 124.03% in 2022 and fell as far as 24.58% in 2022.
- Year by year, Restructuring Costs stood at $916351.0 in 2022, then surged by 37.44% to $1.3 million in 2023, then surged by 45.06% to $1.8 million in 2024, then grew by 2.75% to $1.9 million in 2025, then advanced by 16.24% to $2.2 million in 2026.
- Per Business Quant data, the three most recent Restructuring Costs figures were $2.2 million in Q1 2026, $1.9 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.47 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 916,351.00 |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 639,164.00 |
| Dec 31, 2021 | -3.81 Mn |
| Sep 30, 2021 | 2.21 Mn |
| Jun 30, 2021 | 1.81 Mn |